Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.

ACON Aclarion Inc

0.00 (0.0%)
Nov 28 2023 - Closed
Delayed by 15 minutes
Company Name Stock Ticker Symbol Market Type
Aclarion Inc ACON NASDAQ Common Stock
  Price Change Change Percent Stock Price Last Traded
0.00 0.0% 0.27 19:04:42
Open Price Low Price High Price Close Price Prev Close
0.2891 0.26 0.2891 0.27 0.27
more quote information »

Recent News

Date Time Source Heading
11/27/202308:00GLOBEAclarion Announces Key Commercial Milestone With Completion..
11/22/202316:01EDGAR2Form 8-K - Current report
11/16/202316:58EDGAR2Form 424B3 - Prospectus [Rule 424(b)(3)]
11/13/202306:00EDGAR2Form DEF 14A - Other definitive proxy statements
11/08/202308:00GLOBEAclarion Announces Achievement of Goal to Enroll 10 Leading..
11/06/202308:00GLOBEAclarion Expands Immediate Nociscan Access Into New York..
11/01/202316:15EDGAR2Form PRE 14A - Other preliminary proxy statements
11/01/202308:00GLOBEAclarion Presents at the NIH HEAL Initiative Fall Meeting
10/30/202317:00EDGAR2Form SC 13G - Statement of acquisition of beneficial..
10/25/202308:30GLOBEAclarion Announces Signing of Commercial Agreement With..
10/24/202308:45GLOBEAclarion Announces Nociscan® Cost-Effectiveness Poster..
10/23/202308:55EDGAR2Form 424B3 - Prospectus [Rule 424(b)(3)]
10/23/202307:00GLOBEAclarion Announces Signing Strategic Partnership Letter of..
10/23/202306:00EDGAR2Form 424B3 - Prospectus [Rule 424(b)(3)]
10/23/202300:15EDGAR2Form EFFECT - Notice of Effectiveness
10/20/202315:08EDGAR2Form S-1/A - General form for registration of securities..
10/10/202315:34EDGAR2Form S-1 - General form for registration of securities under..
10/10/202308:30EDGAR2Form 8-K - Current report
10/02/202308:00GLOBEAclarion Provides Updated Investor Presentation and..
9/28/202307:48EDGAR2Form 8-K - Current report
9/07/202316:01EDGAR2Form 8-K - Current report
8/31/202316:01EDGAR2Form 8-K - Current report
8/25/202316:42EDGAR2Form 8-K - Current report
8/25/202316:10GLOBEAclarion, Inc. Announces Filing of Delayed 10-Q Quarterly..
8/25/202313:04EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
8/14/202316:30EDGAR2Form 8-K - Current report
8/14/202316:27EDGAR2Form NT 10-Q - Notification of inability to timely file Form..
8/10/202317:12EDGAR2Form 8-K - Current report
7/14/202316:58EDGAR2Form 8-K - Current report
7/14/202316:06EDGAR2Form 424B3 - Prospectus [Rule 424(b)(3)]
7/12/202317:27EDGAR2Form S-1/A - General form for registration of securities..
7/07/202316:01EDGAR2Form 8-K - Current report
7/03/202316:01EDGAR2Form S-1 - General form for registration of securities under..
7/03/202308:13EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
6/14/202311:27GLOBEAclarion Announces New Commercial Engagement with The..
6/08/202307:30GLOBEAclarion Announces Statistically Significant Nociscan®..
5/30/202307:30GLOBEAclarion Announces New Engagement with The London Clinic and..
5/23/202307:30GLOBEAclarion’s Key Opinion Leader Program Adds Ninth Surgeon..
5/23/202307:00GLOBEAclarion, Inc. Announces Delayed 10-Q Filing
5/19/202307:30GLOBEAclarion Announces Non-Convertible Debt Financing to Achieve..
5/02/202307:00GLOBEAclarion Appoints Nicholas Theodore, MD as Principal..
4/28/202311:20GLOBEAclarion to Host Thought Leadership Symposium at SPINEWEEK..
4/24/202307:00GLOBEAclarion Announces Publication of 2YR Outcomes in..
3/07/202309:19GLOBEAclarion Announces Alpesh Patel MD MBA as a Key Opinion..
2/15/202307:00GLOBEAclarion Supports Thought Leadership at the 2nd Annual..
1/31/202310:01GLOBEGregory Basil MD to Join Aclarion as a Key Opinion Leader..
1/17/202308:29GLOBEAclarion Appoints George Frey MD as Seventh Key Opinion..
12/22/202210:36GLOBEDr. Christopher Ames to Join Aclarion as a Key Opinion..
12/21/202210:23GLOBEAclarion’s Key Opinion Leader Program Adds Fifth Surgeon..
12/19/202208:33GLOBEAclarion Adds to Growing Key Opinion Leader Program with..

Your Recent History